Header Logo

Search Results (73)

More Search Options
MatchTypeWhy
LI, ANGPerson Why?
Complement activation in thrombotic microangiopathies.Academic Article Why?
Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA).Academic Article Why?
Plasma exchange therapy for thrombotic microangiopathies.Academic Article Why?
Thrombotic microangiopathy associated with Valproic acid toxicity.Academic Article Why?
Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.Academic Article Why?
Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy.Academic Article Why?
Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy.Academic Article Why?
Incidence and Risk Factors of Transplantation-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.Academic Article Why?
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.Academic Article Why?
Purtscher-like retinopathy: A rare presentation of hematopoietic stem cell transplant-associated thrombotic microangiopathy.Academic Article Why?
The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.Academic Article Why?
Thrombotic microangiopathies and the linkage between von Willebrand factor and the alternative complement pathway.Academic Article Why?
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.Academic Article Why?
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal.Academic Article Why?
Per Page    Page  of 5last Nextnext
Prev
Search Criteria
  • Thrombotic Microangiopathy
Filter by Type
_
Click "Why?" to see why an item matched the search.